Phacoemulsification and COVID-19 risk

Michael Goggin^{1

2

3}, Brendan Vote⁴

Affiliations

¹ University of Adelaide, Adelaide, South Australia, Australia.
² Department of Ophthalmology, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.
³ South Australian Institute of Ophthalmology, Adelaide, South Australia, Australia.
⁴ University of Tasmania, Hobart, Tasmania, Australia.

Editorial

Michael Goggin et al. Clin Exp Ophthalmol. 2020 Dec.

. 2020 Dec;48(9):1131-1132.

doi: 10.1111/ceo.13869. Epub 2020 Oct 25.

Michael Goggin^{1

2

3}, Brendan Vote⁴

¹ University of Adelaide, Adelaide, South Australia, Australia.
² Department of Ophthalmology, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.
³ South Australian Institute of Ophthalmology, Adelaide, South Australia, Australia.
⁴ University of Tasmania, Hobart, Tasmania, Australia.

No abstract available

References

1. Camus A. The Plague. Melbourne, Australia: Penguin Group. Translation by Robin Buss; 2009.
1. Ulhaq ZS, Soraya GV. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid. Graefes Arch Clin Exp Ophthalmol. 2020;23:1-2.
1. Güemes-Villahoz N, Burgos-Blasco B, Arribi-Vilela A, et al. SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis. J Infect. 2020;81:452-482.
1. Lim LW, Yip LW, Tay HW, et al. Sustainable practice of ophthalmology during COVID-19: challenges and solutions. Graefes Arch Clin Exp Ophthalmol. 2020;258:1427-1436.
1. Aytogan H, Ayintap E, Yilmaz NÖ. Detection of coronavirus disease 2019 viral material on environmental surfaces of an ophthalmology examination room. JAMA Ophthalmol. 2020;e203154. https://dx.doi.org/10.1001/jamaophthalmol.2020.3154. [Epub online ahead of print]